-67
NPS Score
VS
BlueRock Therapeutics Claimed Company
- This companyis accepting feedback from verified employeesEMPLOYEE
PARTICIPANTS - 180
- TOTAL
RATINGS
Intellia Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 12
- TOTAL
RATINGS
BlueRock Therapeutics vs Intellia Therapeutics
Compare BlueRock Therapeutics versus Intellia Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 180 employees and customers of BlueRock Therapeutics and 12 employees and customers of Intellia Therapeutics.
BlueRock Therapeutics
BlueRock Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of BlueRock Therapeutics.
Intellia Therapeutics
Intellia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intellia Therapeutics. Their current market cap is $5.42B.
1.5/5
Product Quality
3.5/5
1.5/5
Pricing
3.3/5
1.5/5
Customer Service
3.9/5
| 0% | Promoters |
|---|---|
| 33% | Passive |
| 67% | Detractors |
49
NPS Score
| 66% | Promoters |
|---|---|
| 17% | Passive |
| 17% | Detractors |
Net Promoter Score
Winner by 116
See how BlueRock Therapeutics compares to its competitors
See how Intellia Therapeutics compares to its competitors
Working at BlueRock Therapeutics vs Working at Intellia Therapeutics
89 / 100
CEO Rating
Winner by 3%
86 / 100
CEO Rating
BlueRock Therapeutics
BlueRock Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Intellia Therapeutics
Employees at Intellia Therapeutics rate their CEO, John Leonard, 86/100. This score is 3% lower than the scores of BlueRock Therapeutics' CEO, SETH ETTENBERG, PH.D..